EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-GuérinSamantha Cambier, Jorg R. Oddens, Maurizio Brausi et al.|European Urology|2015Cited by 639
Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD TrialLiselotte M.S. Boevé, George van Andel, Maarten C.C.M. Hulshof et al.|European Urology|2018Cited by 577